title: [Platelet inhibition remains the second choice. "Anticoagulation should always be the goal" (interview by Dr. med. Jochen Aumiller)].
authors: Stuart
authors: S
authors: Connolly
mesh_terms: D000368:Aged; D000925:Anticoagulants; D001241:Aspirin / Q000627:therapeutic use*; D000077144:Clopidogrel; D000075202:Contraindications; D004359:Drug Therapy, Combination; D006801:Humans; D020766:Intracranial Embolism / Q000517:prevention & control*; D010644:Phenprocoumon; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D010644:Phenprocoumon; D001241:Aspirin